GRP and colonic neoplasm: The over-expression of gastrin releasing peptide (GRP) and its receptor can be discovered after malignant transformation of colon cancer cells, and they can also enhance tumor attachment to the extracellular matrix and promote cytolysis of NK cells (Carroll et al., 2000; Rivera et al., 2009).